Earnings estimate | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 3 | 3 | 2 | 4 |
Avg. Estimate | 2.83 | 3.35 | 14.37 | 15.23 |
Low estimate | 2.59 | 3.19 | 14.35 | 14.09 |
High estimate | 3.01 | 3.44 | 14.4 | 15.65 |
Year ago EPS | 3.71 | 3.21 | 15.66 | 14.37 |
Revenue estimate | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 2 | 2 | 4 | 4 |
Avg. Estimate | 685.24M | 762.41M | 2.84B | 3.04B |
Low estimate | 684.98M | 755.61M | 2.83B | 2.99B |
High estimate | 685.5M | 769.2M | 2.86B | 3.06B |
Year ago sales | 747.05M | 732.77M | 2.92B | 2.84B |
Sales growth (year/est) | -8.30% | 4.00% | -2.80% | 6.80% |
Earnings history | 29/09/2021 | 30/12/2021 | 30/03/2022 | 29/06/2022 |
---|---|---|---|---|
Est. EPS | 2.44 | 2.85 | 3.4 | 2.8 |
Actual EPS | 3.71 | 3.21 | 4.94 | 3.38 |
Difference | 1.27 | 0.36 | 1.54 | 0.58 |
Surprise % | 52.00% | 12.60% | 45.30% | 20.70% |
EPS trend | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Current estimate | 2.83 | 3.35 | 14.37 | 15.23 |
7 days ago | 2.83 | 3.35 | 14.37 | 15.23 |
30 days ago | 3.06 | 3.54 | 14.51 | 15.58 |
60 days ago | 3.06 | 3.54 | 14.51 | 15.58 |
90 days ago | 3.06 | 3.54 | 14.51 | 15.58 |
EPS revisions | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | 2 | 2 |
Up last 30 days | 1 | N/A | 2 | 2 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | 2 | 2 | 1 | N/A |
Growth estimates | BIO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | -23.70% | N/A | N/A | N/A |
Next qtr. | 4.40% | N/A | N/A | N/A |
Current year | -8.20% | N/A | N/A | N/A |
Next year | 6.00% | N/A | N/A | N/A |
Next 5 years (per annum) | 17.80% | N/A | N/A | N/A |
Past 5 years (per annum) | 56.25% | N/A | N/A | N/A |